[go: up one dir, main page]

NO20040346L - Ny krystall av aryletensulfonamid-derivat og fremstillingsprosess derav - Google Patents

Ny krystall av aryletensulfonamid-derivat og fremstillingsprosess derav

Info

Publication number
NO20040346L
NO20040346L NO20040346A NO20040346A NO20040346L NO 20040346 L NO20040346 L NO 20040346L NO 20040346 A NO20040346 A NO 20040346A NO 20040346 A NO20040346 A NO 20040346A NO 20040346 L NO20040346 L NO 20040346L
Authority
NO
Norway
Prior art keywords
arylethylenesulfonamide
derivative
manufacturing process
new crystal
crystal
Prior art date
Application number
NO20040346A
Other languages
English (en)
Inventor
Yoshinori Kato
Hironori Harada
Masahiro Kurotani
Haruhiko Toda
Kenichirou Sakamoto
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of NO20040346L publication Critical patent/NO20040346L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20040346A 2001-07-27 2004-01-26 Ny krystall av aryletensulfonamid-derivat og fremstillingsprosess derav NO20040346L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001227253 2001-07-27
PCT/JP2002/007551 WO2003010152A1 (en) 2001-07-27 2002-07-25 Novel crystal of arylethenesulfonamide derivative and process for producing the same

Publications (1)

Publication Number Publication Date
NO20040346L true NO20040346L (no) 2004-03-24

Family

ID=19059947

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040346A NO20040346L (no) 2001-07-27 2004-01-26 Ny krystall av aryletensulfonamid-derivat og fremstillingsprosess derav

Country Status (14)

Country Link
US (1) US7232904B2 (no)
EP (1) EP1413578A4 (no)
JP (1) JPWO2003010152A1 (no)
KR (1) KR100757701B1 (no)
CN (1) CN1245389C (no)
BR (1) BR0211489A (no)
CA (1) CA2452253C (no)
HU (1) HUP0400869A3 (no)
MX (1) MXPA04000650A (no)
NO (1) NO20040346L (no)
PL (1) PL366889A1 (no)
RU (1) RU2004105867A (no)
WO (1) WO2003010152A1 (no)
ZA (1) ZA200309902B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004010194A1 (de) * 2004-03-02 2005-10-13 Aventis Pharma Deutschland Gmbh 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate, ihre Herstellung und Verwendung in Arzneimitteln
DE102004010207A1 (de) * 2004-03-02 2005-09-15 Aventis Pharma S.A. Neue 4-Benzimidazol-2-yl-pyridazin-3-on-Derivate
WO2006101062A1 (ja) * 2005-03-22 2006-09-28 Daiichi Sankyo Company, Limited 1-アルキルピロリジン構造を有するカルバペネム誘導体の製造方法
TW200639176A (en) * 2005-05-13 2006-11-16 Sankyo Co Crystal of 1-methyl carbapenem compound
CN111689934B (zh) * 2020-06-24 2022-08-02 郑州大学 14-脱羟-13-脱氢穿心莲内酯-12-磺酸钾的单晶体及制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2172735C2 (ru) * 1995-12-20 2001-08-27 Яманоути Фармасьютикал Ко., Лтд. Арилэтенсульфонамидные производные и фармацевтическая композиция

Also Published As

Publication number Publication date
BR0211489A (pt) 2004-08-17
US20040162302A1 (en) 2004-08-19
WO2003010152A1 (en) 2003-02-06
EP1413578A1 (en) 2004-04-28
HUP0400869A3 (en) 2004-10-28
CA2452253A1 (en) 2003-02-06
ZA200309902B (en) 2005-03-14
KR20040018514A (ko) 2004-03-03
RU2004105867A (ru) 2005-06-27
PL366889A1 (en) 2005-02-07
CN1245389C (zh) 2006-03-15
CA2452253C (en) 2009-06-02
JPWO2003010152A1 (ja) 2004-11-18
US7232904B2 (en) 2007-06-19
EP1413578A4 (en) 2004-10-20
KR100757701B1 (ko) 2007-09-14
CN1535265A (zh) 2004-10-06
MXPA04000650A (es) 2004-03-19
HUP0400869A2 (hu) 2004-07-28

Similar Documents

Publication Publication Date Title
NO20044533D0 (no) Fremgangsmate for fremstilling av 7-substituerte 3-kinolin og 3-kinol-4-onkarbonitriler
NO20035177D0 (no) Krystallformer av Azithromycin
NO20034212L (no) Kvartsglasskomponent og fremstilling derav
DE60226928D1 (de) Polyhydroxyalkanoat-enthaltende Struktur und Herstellungsverfahren hierfür
DE60223735D1 (de) Interferometer und zugehöriges Herstellungsverfahren
DE60310339D1 (de) Querträger und Herstellungsverfahren
DE60218767D1 (de) Reissverschluss und Herstellungsverfahren
DE60136927D1 (de) Rfelektiver bedruckter gegenstand und sein herstellungsverfahren
NO20033746L (no) Fremgangsmåte og blanding for syrebehandling av en underjordisk formasjon
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
DE10196531T1 (de) Beschleunigungssensor und Herstellungsverfahren dafür
DE60210535D1 (de) Vibrator und Herstellungsverfahren desselben
DE60220116D1 (de) Zirkularpolarisierendes optisches Element und zugehöriges Herstellungsverfahren
DE60231538D1 (de) Sputtertarget und herstellungsverfahren dafür
DE60233663D1 (de) Siliciummonoxid-sinterprodukt und herstellungsverfahren dafür
DE50214244D1 (de) Klauenpolläufer und dessen herstellverfahren
DE60208383D1 (de) Perrückenaufkleber und herstellungsverfahren
DE60223225D1 (de) Zündkerze und Herstellungsverfahren der Zündkerze
NO20041187L (no) Metoder og blandinger av nye triazinforbindelser
NO20042012L (no) Sammensetning og fremgangsmate for behandling av diabetes
IS7128A (is) Hreinsun á zaleploni og kristölluð form þess
NO20031413L (no) Ny fremgangsmate for fremstilling av oksabispidiner og nytt mellomprodukt
DE60336481D1 (de) Epitaktischer wafer und herstellungsverfahren dafür
NO20023678L (no) Behandling av allergiske og inflammatoriske tilstander
DE60315169D1 (de) Optisches mikrosystem und herstellungsverfahren